Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.400ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.400ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.277EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.277EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.277ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.277ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.277EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.277EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.277ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.277ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.294EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.294EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.294ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.294ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.294EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.294EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.294ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.294ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.81EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.81EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.81ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.81ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.81EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.81EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.81ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.81ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HV.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HV.1.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HV.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HV.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HV.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.2.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.2.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.2.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBJ.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBJ.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBJ.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBJ.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBJ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used